HBEGF encodes a growth factor called heparin-binding epidermal growth factor-like growth factor (HB-EGF), which binds to APP, the transmembrane glycoprotein central to AD, and acts synergistically with EGF to promote ERK signaling and neuritogenesis (da Rocha et al., 2021). The gene discussed is APP; the disease is Alzheimer disease.